Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis A protection in immunodeficient travelers
2009-016055-22Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Oct 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of Epaxal Junior in hepatitis A (HAV) (2 arms), sponsored by Helsinki University Hospital. Started Oct 2009; status: completed.
02
Drugs
Epaxal Junior
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on 2009-016055-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016055-22.